Disambiguation evidence for Gilead Sciences (board member) via surface form
"Gilead Sciences"
As subject (49)
Triples where this entity appears as subject under the
label "Gilead Sciences".
| Predicate | Object |
|---|---|
| country |
United States of America
ⓘ
surface form:
United States
|
| developed | bictegravir ⓘ |
| developed | emtricitabine ⓘ |
| developed | ledipasvir ⓘ |
| developed | remdesivir ⓘ |
| developed | sofosbuvir ⓘ |
| developed | tenofovir alafenamide ⓘ |
| developed | tenofovir disoproxil fumarate ⓘ |
| developed | velpatasvir ⓘ |
| focusesOn | COVID-19 treatment ⓘ |
| focusesOn | HIV treatment ⓘ |
| focusesOn | antiviral drugs ⓘ |
| focusesOn | hepatitis B treatment ⓘ |
| focusesOn | hepatitis C treatment ⓘ |
| founded | 1987 ⓘ |
| foundedBy | John C. Martin NERFINISHED ⓘ |
| foundedBy | Michael L. Riordan ⓘ |
| foundedBy | Other early co-founders and investors ⓘ |
| foundedBy | Paris Panayiotopoulos ⓘ |
| foundedIn |
California, United States
ⓘ
surface form:
California
|
| hasBoardOfDirectors | yes ⓘ |
| headquartersLocation |
Foster City, California
ⓘ
surface form:
Foster City, California, United States
|
| industry | biotechnology ⓘ |
| industry | pharmaceuticals ⓘ |
| instanceOf | biopharmaceutical company ⓘ |
| instanceOf | public company ⓘ |
| isMajorCompanyIn | antiviral drug development ⓘ |
| knownFor | HIV antiretroviral drugs ⓘ |
| knownFor | development of antiviral therapies ⓘ |
| knownFor | hepatitis C direct-acting antivirals ⓘ |
| listedOn | NASDAQ ⓘ |
| operatesIn | global market ⓘ |
| product | Biktarvy ⓘ |
| product | Descovy ⓘ |
| product | Epclusa ⓘ |
| product | Harvoni ⓘ |
| product | Sovaldi ⓘ |
| product | Truvada ⓘ |
| product | Veklury ⓘ |
| researchFocus | infectious diseases ⓘ |
| researchFocus | inflammation ⓘ |
| researchFocus | oncology ⓘ |
| revenueSource | prescription drugs ⓘ |
| specializesIn | COVID-19 therapeutics ⓘ |
| specializesIn | HIV/AIDS therapeutics ⓘ |
| specializesIn | inflammatory diseases ⓘ |
| specializesIn | oncology ⓘ |
| specializesIn | viral hepatitis therapeutics ⓘ |
| tickerSymbol | GILD ⓘ |
As object (3)
Triples where some other subject referred to this entity
as "Gilead Sciences".